<p>Clinical Characteristics and Prognosis of Gastric Cancer Patients with <em>BRCA 1/2</em> Germline Mutations: Report of Ten Cases and a Literature Review</p>-Reference-Cited by-同舟云学术

Clinical Characteristics and Prognosis of Gastric Cancer Patients with BRCA 1/2 Germline Mutations: Report of Ten Cases and a Literature Review

Published:2020-11 Issue: Volume:Volume 13 Page:11637-11644
ISSN:1178-6930
Container-title:OncoTargets and Therapy
language:en
Short-container-title:OTT

Author:

Halpern Naama^ORCID,Grinshpun Albert,Boursi Ben,Golan Talia,Margalit Ofer,Aderka Dan,Friedman Eitan^ORCID,Laitman Yael,Hubert Ayala,Kadouri Luna^ORCID,Hamburger Tamar,Barnes-Kedar Inbal,Levi Zohar,Ben-Aharon Irit,Brenner Baruch,Goldberg Yael,Peretz Tamar,Shacham-Shmueli Einat

Publisher

Informa UK Limited

Subject

Pharmacology (medical),Oncology

Reference27 articles.

1. Global cancer statistics

2. Olaparib Monotherapy in Patients With Advanced Cancer and a Germline BRCA1/2 Mutation

3. Olaparib for Metastatic Breast Cancer in Patients with a Germline BRCA Mutation

4. Phase 1 trial evaluating cisplatin, gemcitabine, and veliparib in 2 patient cohorts: GermlineBRCAmutation carriers and wild-typeBRCApancreatic ductal adenocarcinoma

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Advancements and Obstacles of PARP Inhibitors in Gastric Cancer;Cancers;2023-10-24

2. Gastric Cancer Risk and Pathogenesis in BRCA1 and BRCA2 Carriers;Cancers;2022-12-01

3. DNA Damage Repair and Current Therapeutic Approaches in Gastric Cancer: A Comprehensive Review;Frontiers in Genetics;2022-08-12

4. Molecular pathogenesis and emerging targets of gastric adenocarcinoma;Journal of Surgical Oncology;2022-04-28

5. Response inBRCA1mutation carrier with metastatic pancreatic adenocarcinoma treated with FOLFIRINOX;BMJ Case Reports;2022-04